prof. MUDr. Danka Švecová, PhD.
Vedecko/umelecko-pedagogická charakteristika:
Najvýznamnejšie výstupy tvorivej činnosti: VTC1, VTC2, VTC3, VTC4, VTC5
1. | Švecová D, Šimaljakova M, Doležalová A. Footwear contact dermatitis from dimethyl fumarate. International Journal of Dermatology. 2013 | Q3 | IF 1,227 |
2. | Svecova D, Parnicka Z, Pastyrikova L, Urbancek S, Luha J, Buc M. HLA DRB1* and DQB1* alleles are associated with disease severity in patients with pemphigus vulgaris. International Journal of Dermatology. 2015 | Q3 | IF 1,415 |
3. | Svecova D. IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects. Australasian Journal of Dermatology. 2016 | Q3 | IF 1,304 |
4. | Svecova D, Lubell MW, Casset-Semanaz F, Mackenzie H, Grenningloh R, Krueger JG. A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe psoriasis. Journal of the American Academy of Dermatology. 2019 | Q1 | IF 8,277 |
5. | Svecova D. Pemphigus vulgaris: a clinical study of 44 cases over a 20-year period. International Journal of Dermatology. 2015 | Q3 | IF 1,415 |